Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Active Biotech announce that European Medicines Agency accepts start of scientific review of the marketing authorization application for laquinimod in relapsing-remitting multiple sclerosis
Association mapping of disease loci, by use of a pooled DNA genomic screen.
Tysabri
Ocrelizumab in multiple sclerosis: risks and benefits.
Modulation of IL-2Rα with daclizumab for treatment of multiple sclerosis.
The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.
Cytochrome P450 3A4 is the major enzyme responsible for the metabolism of laquinimod, a novel immunomodulator.
Randomized, open-label study to evaluate patient-reported outcomes with fingolimod after changing from prior disease-modifying therapy for relapsing multiple sclerosis: EPOC study rationale and design.
Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
Cerebrospinal fluid detection of interleukin-1beta in phase of remission predicts disease progression in multiple sclerosis.
Platelets Contribute to the Pathogenesis of Experimental Autoimmune Encephalomyelitis.
Validity and Reliability of a Persian Translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS).
Effects of Dalfampridine Extended-Release Tablets on 6-Minute Walk Distance in Patients With Multiple Sclerosis: A Post Hoc Analysis of a Double-Blind, Placebo-Controlled Trial.
Sustained disease-activity-free status in patients with relapsing-remitting multiple sclerosis treated with cladribine tablets in the CLARITY study: a post-hoc and subgroup analysis.
Interferon beta-1a in primary progressive MS: an exploratory, randomized, controlled trial.
Sustained disability improvement is associated with T1 lesion volume shrinkage in natalizumab-treated patients with multiple sclerosis.
Alemtuzumab-based induction treatment versus basiliximab-based induction treatment in kidney transplantation (the 3C Study): a randomised trial.
DemTect, PANDA, EASY, and MUSIC: Cognitive Screening Tools with Age Correction and Weighting of Subtests According to Their Sensitivity and Specificity.
Sensitivity and specificity of SWI venography for detection of cerebral venous alterations in multiple sclerosis.
Immunology 2012
Mapi Pharma granted United States patent covering glatiramer depot for multiple sclerosis
Cerebrospinal fluid biomarkers of β-amyloid metabolism in multiple sclerosis.
Santhera receives first product approval: Health Canada approves Catena® for treatment of Friedreich's ataxia
Concurrent saturation transfer contrast in in vivo brain by a uniform magnetization transfer MRI.
Pharmacological protection of CNS white matter during anoxia: actions of phenytoin, carbamazepine and diazepam.

Pages